{
    "nctId": "NCT01381315",
    "briefTitle": "Axillary Reverse Mapping",
    "officialTitle": "ARM: Axillary Reverse Mapping",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 210,
    "primaryOutcomeMeasure": "Assess lymphedema rates",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* 18 - 100 years old\n* Not pregnant or breastfeeding\n* Diagnosis of breast cancer requiring LN evaluation for ipsilateral or contralateral breast or prophylactic mastectomy\n* Willing participation after obtaining informed consent\n\nExclusion Criteria:\n\n* \\< 18 or \\> 100 years of age\n* Pregnant or breastfeeding\n* Blue dye allergy\n* Cosmetic allergy\n* History of primary lymphedema\n* Prior breast augmentation",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}